A REVIEW OF OPPORTUNITY COST DEFINE

Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, especially for cancers where cure solutions remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidate